AVR and TB Commodities Stockouts

Communities impacted by TB and HIV voiced their concern over the discouraging outcome of the Kisumu petition E008 of 2023. This ruling undermines progress and discourages future efforts to seek justice through the courts. We had expected the Judiciary to stand with the people and not against them. The Kisumu petitioners demand a long term strategy for ARV provision. There is a public echo for that call that plans should be in place for future solutions. Victims deserve compensation caused by the above outcomes. This is something that needs to be addressed in order to avoid more pain to the wananchi.

The fight against TB and HIV cannot be won without legal frameworks that protects the rights of those affected. The dispute has left thousands of patients without access to HIV and TB drugs. We demand urgent reforms which should focus on long term solutions to guide against such disasters. Healthcare of the common mwananchi should not be taken for granted since taxpayers are funding KEMSA.

We demand accountability from the Kenyan Government as we can't hold American President, Donald Trump to be responsible for the challenges we are facing. It's time that our Government ensures systems run efficiently. There are also concerns concerning mismanagement at KEMSA. The inefficiencies at KEMSA. This is outright corruption leading to the unnecessary deaths of innocent Kenyans.

Justice delayed is justice denied. The case had dragged on for so long, creating anxiety during the whole time it dragged. The affected persons continue to endure stigma which affects their standing within their communities.

TB remains the leading cause of death among HIV positive patients. If it's not being addressed to reduce it's spread, such patients are staring closer to death rather than having hopes. This is even despite the fact that TB is preventable, treatable and curable. It should not be among the world's deadliest diseases since it is treatable.